GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 2 filers reported holding GEMINI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $167,000 | -2.9% | 101,899 | 0.0% | 0.00% | – |
| Q2 2022 | $172,000 | -69.7% | 101,899 | -75.1% | 0.00% | – |
| Q1 2022 | $568,000 | -52.7% | 408,704 | -0.9% | 0.00% | – |
| Q4 2021 | $1,200,000 | -28.5% | 412,215 | -0.7% | 0.00% | – |
| Q3 2021 | $1,678,000 | -15.8% | 415,311 | +34.8% | 0.00% | – |
| Q2 2021 | $1,994,000 | +682.0% | 308,141 | +1539.0% | 0.00% | – |
| Q1 2021 | $255,000 | – | 18,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $15,755,000 | 6.20% |
| Orbimed Advisors | 5,826,224 | $37,696,000 | 0.38% |
| Boxer Capital, LLC | 1,300,000 | $8,411,000 | 0.30% |
| Ikarian Capital, LLC | 426,455 | $2,759,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,135,000 | $13,813,000 | 0.21% |
| JS Capital Management LLC | 474,457 | $3,070,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 250,000 | $1,618,000 | 0.09% |
| Alyeska Investment Group, L.P. | 837,584 | $5,419,000 | 0.06% |
| Virtus ETF Advisers LLC | 19,673 | $127,000 | 0.05% |
| Caption Management, LLC | 384,900 | $2,488,000 | 0.03% |